Targeting TGFβ signal transduction for cancer therapy.
Liu S, Ren J, Ten Dijke P. · 2021
Read Targeting TGFβ signal transduction for cancer therapy. by Liu S, Ren J, Ten Dijke P. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7791126.txt.
Description
Liu and co-authors review efforts to block TGFβ signaling as cancer therapy. TGFβ family proteins guide cell fate in development. They also keep adult tissues in balance. Faulty signaling feeds cancer, immune disorders, and fibrosis.
TGFβ plays a double role in cancer. Early on it suppresses tumors. Later it helps them grow and spread. It also shapes the tumor surroundings. It boosts matrix buildup and blood vessel growth. It mutes the immune attack on tumors. Trials of TGFβ blockers are summed up. The hard part is blocking it without harming healthy tissue. Remaining challenges close the review.
Catalog record
| CREATOR | Liu S, Ren J, Ten Dijke P. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 123 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |